Skip to main content

Advertisement

SpringerLink
Log in

Neuralgic amyotrophy triggered by hepatitis E virus: a particular phenotype

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

The neuralgic amyotrophy may be of difficult diagnosis, due to phenotypic variability, with different initial presentations (upper plexus multiple mononeuropathy, lumbosacral involvement, distal reached, phrenic involvement). To date, there is little guidance on these patients’ therapeutic management, especially those for which neuralgic amyotrophy is triggered by hepatitis E virus (HEV-NA). The study aims to identify specific features that characterize patients bearing the neuralgic amyotrophy triggered by HEV. We first describe a new case report of HEV-neuralgic amyotrophy, with delayed diaphragmatic reach. Then, the literature was searched for reports of HEV-NA (n = 39), and neuralgic amyotrophy with phrenic paresis (n = 42) from 1999 to June 2016. Relevant data were retrieved, analyzed and compared with the parameters of idiopathic neuralgic amyotrophy (n = 199) of the largest cohort, described by Van Alfen and Van Engelen in 2006. Compared to the published cohort, HEV-NA patients were more likely to be men (M/F 34/5 vs. 136/63, p = 0.017), with more frequent bilateral symptoms (86.8% cases vs. 28.5%, p < 0.0001) as well as phrenic paresis (18.0 vs. 6.6%, p = 0.028). The clinical improvement is poor, with 15.6% of cases with remission only. A particular phenotype characteristic of the HEV-induced neuralgic amyotrophy has arisen. Our findings call for action in validating the above-mentioned features that illustrate the HEV-NA cases as an early diagnosis would prevent complications, especially the phrenic damage often associated with a worse functional outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Van Eijk JJJ, Groothuis JT, Van Alfen N (2016) Neuralgic amyotrophy: an update on diagnosis, pathophysiology, and treatment. Muscle Nerve 53:337–350

    Article  PubMed  Google Scholar 

  2. Van Alfen N (2011) Clinical and pathophysiological concepts of neuralgic amyotrophy. Nat Rev Neurol 7:315–322

    Article  PubMed  Google Scholar 

  3. Van Alfen N, Van Eijk JJJ, Ennik T et al (2015) Incidence of neuralgic amyotrophy (Parsonage Turner syndrome) in a primary care setting—a prospective cohort study. PLoS ONE 10:e0128361

    Article  PubMed  PubMed Central  Google Scholar 

  4. Van Alfen N, Van Engelen BGM (2006) The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain 129:438–450

    Article  PubMed  Google Scholar 

  5. Cup EH, Ijspeert J, Janssen RJ et al (2013) Residual complaints after neuralgic amyotrophy. Arch Phys Med Rehabil 94:67–73

    Article  PubMed  Google Scholar 

  6. Dartevel A, Colombe B, Bosseray A et al (2015) Hepatitis E and neuralgic amyotrophy: five cases and review of literature. J Clin Virol 69:156–164

    Article  PubMed  Google Scholar 

  7. Van Eijk JJJ, Madden RG, Van Der Eijk AA et al (2014) Neuralgic amyotrophy and hepatitis E virus infection. Neurology 82:498–503

    Article  PubMed  PubMed Central  Google Scholar 

  8. Dalton HR, Webb GW, Norton BC, Woolson KL (2016) Hepatitis E virus: time to change the textbooks. Dig Dis 34:308–316

    Article  PubMed  Google Scholar 

  9. Rose N, Lunazzi A, Dorenlor V et al (2011) High prevalence of hepatitis E virus in French domestic pigs. Comp Immunol Microbiol Infect Dis 34:419–427

    Article  PubMed  Google Scholar 

  10. Kamar N, Marion O, Abravanel F, Izopet J, Dalton HR (2016) Extrahepatic manifestations of hepatitis E virus. Liver Int 36:467–472

    Article  PubMed  Google Scholar 

  11. Fong F, Illahi M (2009) Neuralgic amyotrophy associated with hepatitis E virus. Clin Neurol Neurosurg 11:193–195

    Article  Google Scholar 

  12. Rianthavorn P, Thongmee C, Limpaphayom N, Komolmit P, Theamboonlers A, Poovorawan Y (2010) The entire genome sequence of hepatitis E virus genotype 3 isolated from a patient with neuralgic amyotrophy. Scand J Infect Dis 42:395–400

    Article  CAS  PubMed  Google Scholar 

  13. Kamar N, Bendall RP, Peron JM et al (2011) Hepatitis E virus and neurologic disorders. Emerg Infect Dis 17:173–179

    Article  PubMed  PubMed Central  Google Scholar 

  14. Carli P, Landais C, Poisnel E et al (2012) Le syndrome d’Aesculape. Rev Méd Interne 33:111–114

    Article  CAS  PubMed  Google Scholar 

  15. Inghilleri ML, Grini Mazouzi M, Juntas Morales R (2012) Neuralgic amyotrophy as a manifestation of hepatitis E infection. Rev Neurol (Paris) 168:383–384

    Article  Google Scholar 

  16. Cheung MCM, Maguire J, Carey I, Wendon J, Agarwal K (2012) Hepatitis E—an unexpected problem at home. Scand J Gastroenterol 47:253

    Article  CAS  PubMed  Google Scholar 

  17. Peri AM, Milazzo L, Meroni L, Antinori S (2013) Radiculoneuropathy associated with acute hepatitis E. Dig Liver Dis 45:963–964

    Article  PubMed  Google Scholar 

  18. Deroux A, Belbézier A, Hyerle L et al (2013) Hépatite E et troubles neurologiques: une association à ne pas méconnaître ! Rev Méd Interne 34(suppl2):A59–A60

    Article  Google Scholar 

  19. Valence M, Cador B, Jezequel C, Pinel JF, Jego P (2014) Syndrome de Parsonage et Turner et hépatite E: un nouveau cas. Rev Méd Interne 35(suppl2):A124–A125

    Article  Google Scholar 

  20. Chirio D, Demonchy E, Laffon M et al (2014) Syndrome de Parsonage Turner et hépatite E: à propos de deux cas. Rev Méd Interne 235(suppl2):A124–A124

    Article  Google Scholar 

  21. Motte A, Franques J, Weitten T, Colson P (2014) Hepatitis E-associated Parsonage–Turner syndrome, France. Clin Res Hepatol Gastroenterol 38:e11–e14

    Article  PubMed  Google Scholar 

  22. Moisset X, Vitello N, Bicilli E, et al (2014) Case report: Severe bilateral amyotrophic neuralgia associated with major dysphagia secondary to acute hepatitis E. F1000Res

  23. Deroux A, Brion JP, Hyerle L et al (2014) Association between hepatitis E and neurological disorders: two case studies and literature review. J Clin Virol 60:60–62

    Article  CAS  PubMed  Google Scholar 

  24. Woolson KL, Forbes A, Vine L et al (2014) Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment Pharmacol Ther 40:1282–1291

    Article  CAS  PubMed  Google Scholar 

  25. Theochari E, Vincent-Smith L, Ellis C (2015) Neuralgic amyotrophy complicating acute hepatitis E infection: a rare association. BMJ Case Rep 2015:bcr2014207669

    Article  PubMed  PubMed Central  Google Scholar 

  26. Décard BF, Grimm A, Andelova M et al (2015) Hepatitis-E virus associated neuralgic amyotrophy with sustained plexus brachialis swelling visualized by high-resolution ultrasound. J Neurol Sci 351:208–210

    Article  PubMed  Google Scholar 

  27. Frezel N, Cassim F, Derambure P, Bocquillon P (2015) syndrome de Parsonage–Turner: diagnostic topographique. Pratique Neurologique-FMC 6:212–217

    Article  Google Scholar 

  28. Blasco Perrin H, Cintas P, Abravanel F et al (2015) Neurologic disorders in immunocompetent patients with autochthonous acute hepatitis E. Emerg Infect Dis 21:1928–1934

    PubMed  PubMed Central  Google Scholar 

  29. Avila JD, Lacomis D, Lam E (2015) Neuralgic amyotrophy with phrenic neuropathy associated with hepatitis E virus infection. Muscle Nerve 52(suppl):S47–S47

    Google Scholar 

  30. Martínez Rodríguez L, Carvajal P, Morís G (2015) Neuralgic amyotrophy associated to hepatitis E virus infection. Med Clín 145:462–463

    Article  Google Scholar 

  31. Silva M, Wicki B, Tsouni P et al (2016) Hepatitis E virus infection as a direct cause of neuralgic amyotrophy. Muscle Nerve 54:325–327

    Article  CAS  PubMed  Google Scholar 

  32. Bisciglia M, Van den Bergh P, Duprez T, Kabamba BM, Ivanoiu A (2016) Neuralgic amyotrophy associated with hepatitis E virus (HEV) infection: a case report. Acta Neurol Belg 1–3

  33. Drave SA, Debing Y, Walter S et al (2016) Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cells. J Viral Hepat 23:512–521

    Article  CAS  PubMed  Google Scholar 

  34. Cruz-Martínez A, Barrio M, Arpa J (2002) Neuralgic amyotrophy: variable expression in 40 patients. J Peripher Nerv Syst 7:198–204

    Article  PubMed  Google Scholar 

  35. Hughes PD, Polkey MI, Moxham J, Green M (1999) Long-term recovery of diaphragm strength in neuralgic amyotrophy. Eur Respir J 13:379–384

    Article  CAS  PubMed  Google Scholar 

  36. Podnar S (2014) Nosology of idiopathic phrenic neuropathies. J Neurol 262:558–562

    Article  PubMed  Google Scholar 

  37. Mengel AM, Stenzel W, Meisel A, Büning C (2016) Hepatitis E–induced severe myositis. Muscle Nerve 53:317–320

    Article  PubMed  Google Scholar 

  38. Tsairis P, Dyck PJ, Mulder DW (1972) Natural history of brachial plexus neuropathy. Report on 99 patients. Arch Neurol 27:109–117

    Article  CAS  PubMed  Google Scholar 

  39. Van Eijk JJJ, Van Alfen N, Berrevoets M, Van der Wilt GJ, Pillen S, Van Engelen BGM (2009) Evaluation of prednisolone treatment in the acute phase of neuralgic amyotrophy: an observational study. J Neurol Neurosurg Psychiatry 80:1120–1124

    Article  PubMed  Google Scholar 

  40. Pischke S, Hardtke S, Bode U et al (2013) Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int 33:722–726

    Article  CAS  PubMed  Google Scholar 

Download references

Author contributions

Conception and design: QS and SMD. Collection data (case report): QS, TP, FC, OO, AL, PYH, ML and SMD. Collection and assembly of data (review): QS. Data analysis: QS. Interpretation: QS and SM. Manuscript drafting: QS and SMD. Final approval of manuscript: QS, TP, FC, OO, AL, PYH, ML and SMD.

Acknowledgements

The authors thank Laura Ravasi MD-PhD. who provided medical writing services and Hélène Béhal for statistical advice on behalf of the University of Lille.

They are grateful to the National Reference Center for Hepatitis E Virus in Toulouse, France, for HEV genotype analysis.

Author information

Authors and Affiliations

  1. Internal Medicine Department, National Reference Center for Rare Autoimmune Systemic Diseases, FHU IMMINeNT, Medical School Henri Warembourg, Lille University Hospital, 59000, Lille, France

    Quentin Scanvion, Aurélia Lanteri, Pierre-Yves Hatron, Marc Lambert & Sandrine Morell-Dubois

  2. Pneumology Department, Medical School Henri Warembourg, Lille University Hospital, 59000, Lille, France

    Thierry Perez

  3. Neurophysiology Department, Medical School Henri Warembourg, Lille University Hospital, 59000, Lille, France

    François Cassim

  4. Neurology Department, Medical School Henri Warembourg, Lille University Hospital, 59000, Lille, France

    Olivier Outteryck

Authors
  1. Quentin Scanvion
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thierry Perez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. François Cassim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Olivier Outteryck
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aurélia Lanteri
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pierre-Yves Hatron
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Marc Lambert
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sandrine Morell-Dubois
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Quentin Scanvion.

Ethics declarations

Conflicts of interest

All authors report no disclosures relevant to the manuscript.

Ethical standards

The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinski and its later amendments.

Funding

None.

Informed consent

First and last authors had received consent from the patient whose case is reported.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 82 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scanvion, Q., Perez, T., Cassim, F. et al. Neuralgic amyotrophy triggered by hepatitis E virus: a particular phenotype. J Neurol 264, 770–780 (2017). https://doi.org/10.1007/s00415-017-8433-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-017-8433-z

Keywords

Search

Navigation